Martin Schlapschy

PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins

Martin Schlapschy, Uli Binder, Carsten Börger et al. · Protein Engineering Design and Selection · 2013 · 326 citations · Full text

Peptide Engineering, Molecular Biology, Biological Alternative +19

Fusion of a recombinant antibody fragment with a homo-amino-acid polymer: effects on biophysical properties and prolonged plasma half-life

Martin Schlapschy, Ina Theobald, Hildegard I. D. Mack et al. · Protein Engineering Design and Selection · 2007 · 97 citations · Full text

Immunocytochemical Technique, Engineering, Protein Assembly +22

A system for concomitant overexpression of four periplasmic folding catalysts to improve secretory protein production in Escherichia coli

Martin Schlapschy · Protein Engineering Design and Selection · 2006 · 95 citations · Full text

Engineering, Protein Assembly, Molecular Biology +16

PASylation of Murine Leptin Leads to Extended Plasma Half-Life and Enhanced <i>in Vivo</i> Efficacy

Volker Morath, Florian Bolze, Martin Schlapschy et al. · Molecular Pharmaceutics · 2015 · 73 citations · Full text

Murine Leptin, Leptin Version, Gastrointestinal Peptide Hormone +14

High contrast tumor imaging with radio-labeled antibody Fab fragments tailored for optimized pharmacokinetics via PASylation

Claudia T. Mendler, Lars Friedrich, Iina Laitinen et al. · mAbs · 2014 · 70 citations · Full text

Engineering, Oncologic Imaging, Imaging Agent +22